AC MF_03127; DC Protein; auto c? TR HAMAP; MF_03127; -; 1; level=0 XX Names: Adenylosucc_synth_vert_acid XX ID PURA2 DE RecName: Full=Adenylosuccinate synthetase isozyme 2; DE Short=AMPSase 2; DE Short=AdSS 2; DE EC=6.3.4.4; DE AltName: Full=Adenylosuccinate synthetase, acidic isozyme; DE AltName: Full=Adenylosuccinate synthetase, liver isozyme; DE Short=L-type adenylosuccinate synthetase; DE AltName: Full=IMP--aspartate ligase 2; GN Name=ADSS; Synonyms=ADSS2; XX CC -!- FUNCTION: Plays an important role in the de novo pathway and in the CC salvage pathway of purine nucleotide biosynthesis. Catalyzes the first CC commited step in the biosynthesis of AMP from IMP. CC -!- CATALYTIC ACTIVITY: CC Reaction=GTP + IMP + L-aspartate = GDP + 2 H(+) + N(6)-(1,2- CC dicarboxyethyl)-AMP + phosphate; Xref=Rhea:RHEA:15753, CC ChEBI:CHEBI:15378, ChEBI:CHEBI:29991, ChEBI:CHEBI:37565, CC ChEBI:CHEBI:43474, ChEBI:CHEBI:57567, ChEBI:CHEBI:58053, CC ChEBI:CHEBI:58189; EC=6.3.4.4; CC -!- COFACTOR: CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Note=Binds 1 Mg(2+) ion per subunit.; CC -!- PATHWAY: Purine metabolism; AMP biosynthesis via de novo pathway; AMP CC from IMP: step 1/2. CC -!- SUBUNIT: Homodimer. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- SIMILARITY: Belongs to the adenylosuccinate synthetase family. XX DR PROSITE; PS01266; ADENYLOSUCCIN_SYN_1; 1; trigger=no DR PROSITE; PS00513; ADENYLOSUCCIN_SYN_2; 1; trigger=no DR Pfam; PF00709; Adenylsucc_synt; 1; trigger=no DR NCBIfam; TIGR00184; PurA; 1; trigger=no XX KW Cytoplasm KW GTP-binding KW Ligase KW Magnesium KW Metal-binding KW Nucleotide-binding KW Purine biosynthesis case KW Acetylation end case XX GO GO:0004019; F:adenylosuccinate synthase activity GO GO:0005525; F:GTP binding GO GO:0000287; F:magnesium ion binding GO GO:0006164; P:purine nucleotide biosynthetic process GO GO:0005737; C:cytoplasm XX FT From: PURA2_HUMAN (P30520) case FT INIT_MET 1 FT /note="Removed" FT Optional; Group: 1; Condition: M FT CHAIN 2..Cter FT /note="Adenylosuccinate synthetase isozyme 2" FT Group: 1 FT MOD_RES 2 FT /note="N-acetylalanine" FT Optional; Group: 1; Condition: A end case FT BINDING 39..45 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT Condition: G-D-E-G-K-G-K FT BINDING 67..69 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT Condition: G-H-T FT BINDING 362..364 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT Condition: K-L-D FT BINDING 444..447 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT Condition: G-V-G-K FT BINDING 40..43 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT Condition: D-E-G-K FT BINDING 65..68 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT Condition: N-A-G-H FT BINDING 330..336 FT /ligand="substrate" FT Condition: x-x-T-x-[KR]-x-R FT ACT_SITE 40 FT /note="Proton acceptor" FT Condition: D FT ACT_SITE 68 FT /note="Proton donor" FT Condition: H FT BINDING 40 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT Condition: D FT BINDING 67 FT /ligand="Mg(2+)" FT /ligand_id="ChEBI:CHEBI:18420" FT Condition: G FT BINDING 40 FT /ligand="substrate" FT Condition: D FT BINDING 162 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT Condition: T FT BINDING 176 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT /ligand_note="ligand shared between dimeric partners" FT Condition: R FT BINDING 255 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT Condition: N FT BINDING 270 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT Condition: T FT BINDING 334 FT /ligand="IMP" FT /ligand_id="ChEBI:CHEBI:58053" FT Condition: R FT BINDING 336 FT /ligand="GTP" FT /ligand_id="ChEBI:CHEBI:37565" FT Condition: R XX Size: 451-457; Related: MF_03125; MF_03126; Template: P30520; P0A7D4; Scope: Eukaryota; Vertebrata Fusion: Nter: None Cter: None Duplicate: in XENTR Plasmid: None Comments: None XX # Revision 1.11 2023/06/01 //